- Home
- SBLX vs SPRC Comparison
SBLX vs SPRC Comparison
Compare SBLX & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SBLX | SPRC |
|---|---|---|
| Founded | 2017 | 2004 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8M | 4.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SBLX | SPRC |
|---|---|---|
| Price | $2.57 | $1.35 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 129.5K | ★ 1.3M |
| Earning Date | 11-14-2025 | 03-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,306,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 187.98 |
| 52 Week Low | $2.32 | $1.25 |
| 52 Week High | $13.60 | $37.59 |
Technical Indicators
Market Signals| Indicator | SBLX | SPRC |
|---|---|---|
| Relative Strength Index (RSI) | 37.25 | 30.96 |
| Support Level | $2.43 | $1.25 |
| Resistance Level | $3.57 | $1.56 |
| Average True Range (ATR) | 0.42 | 0.13 |
| MACD | -0.06 | 0.03 |
| Stochastic Oscillator | 10.19 | 14.38 |
Price Performance
Historical ComparisonAbout SBLX StableX Technologies Inc.
StableX Technologies Inc designs and manufactures compact, sustainable electric vehicles for closed campus mobility, low-speed urban and community transport, local on-demand and last-mile delivery, and government use. It operates as one reportable segment, focusing on the manufacturing and sales of environmentally-conscious, minimal-footprint EVs.
About SPRC SciSparc Ltd.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.